This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Exelixis Inc
EXEL : NASDAQ : Health Care
$4.12 -0.03 | -0.72%
Today's Range: 4.08 - 4.20
Avg. Daily Volume: 3,975,400
08/27/14 - 4:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
EXEL EXELIXIS INC 4.09 798.00 n/m 21.28 -50.11
EBS EMERGENT BIOSOLUTIONS INC 23.72 888.95 67.77 351.42 22.55
GHDX GENOMIC HEALTH INC 28.08 885.28 n/m 272.29 10.74
SRPT SAREPTA THERAPEUTICS INC 21.49 879.46 n/m 15.47 -30.76
ANAC ANACOR PHARMACEUTICALS INC 20.17 847.06 13.36 19.19 76.12
CMRX CHIMERIX INC 23.09 823.60 n/m 3.49 35.32
LXRX LEXICON PHARMACEUTICALS INC 1.48 761.93 n/m 2.60 123.45
ENTA ENANTA PHARMACEUTICALS INC 39.48 733.66 22.18 46.45 1532.79
OREX OREXIGEN THERAPEUTICS INC 5.68 696.00 n/m 3.43 0.00
RPTP RAPTOR PHARMACEUTICAL CORP 11.08 695.19 n/m 45.30 215604.76
ARWR ARROWHEAD RESEARCH CORP 12.72 673.00 n/m 0.17 -40.21
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

EXEL Ind Avg S&P 500
n/m 79.66 19.76

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs